Targeted Monoclonal Antibodies Replace Steroids in Treating Polymyalgia Rheumatica with Lower Relapse Rates
In a small clinic in Berlin, a 68-year-old woman with polymyalgia rheumatica walked out without a steroid prescription for the first time in five years, her inflammation markers down and her mobility restored — a moment captured by rheumatologists at …